BlackRock Amends Sanofi Stake, Maintains Significant Holding
Ticker: SNYNF · Form: SC 13G/A · Filed: Feb 6, 2024 · CIK: 1121404
| Field | Detail |
|---|---|
| Company | Sanofi (SNYNF) |
| Form Type | SC 13G/A |
| Filed Date | Feb 6, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**BlackRock still owns a big chunk of Sanofi, signaling institutional confidence.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on February 6, 2024, disclosing its ownership of Sanofi's Common Stock as of December 31, 2023. This filing, Amendment No. 8, indicates that BlackRock continues to hold a significant, though not necessarily controlling, stake in the pharmaceutical giant. For investors, this matters because BlackRock is one of the world's largest asset managers, and its continued substantial holding in Sanofi suggests a long-term institutional belief in the company's value, potentially signaling stability or confidence in its future performance.
Why It Matters
This filing shows BlackRock, a major institutional investor, continues to hold Sanofi stock, which can be seen as a vote of confidence in the company's long-term prospects.
Risk Assessment
Risk Level: low — This filing is routine for large institutional investors and does not indicate any immediate negative or positive risk for Sanofi.
Analyst Insight
Investors should note BlackRock's continued presence as a major shareholder, which may signal stability, but should conduct their own due diligence on Sanofi's fundamentals before making investment decisions.
Key Players & Entities
- BlackRock Inc. (company) — the entity filing the SC 13G/A, reporting its ownership in Sanofi
- Sanofi (company) — the subject company whose Common Stock is being reported on
- December 31, 2023 (date) — the date of the event which required the filing of this statement
- February 6, 2024 (date) — the date the SC 13G/A amendment was filed
Forward-Looking Statements
- BlackRock will maintain a significant, long-term investment in Sanofi. (BlackRock Inc.) — high confidence, target: December 31, 2024
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as indicated by 'FORM TYPE: SC 13G/A' and 'Amendment No: 8'.
Who is the filer of this SC 13G/A?
The filer of this SC 13G/A is BlackRock Inc., as stated under the 'FILED BY' section.
What company's securities are being reported on in this filing?
The securities being reported on belong to Sanofi, as indicated under 'SUBJECT COMPANY' and 'Name of Issuer: SANOFI'.
What was the date of the event that triggered this filing?
The date of the event which required the filing of this statement was December 31, 2023, as specified in the filing.
What is the SEDOL Number for the class of securities reported?
The SEDOL Number for the Common Stock of Sanofi is B01DR51, as listed in the filing.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on February 6, 2024 regarding Sanofi (SNYNF).